Home » Living with Neuroendocrine Cancer » Lanreotide vs Octreotide

Lanreotide vs Octreotide

Recent Posts


somatuline-depot-injection-vs-sandostatin

long acting Lanreotide (left) – long acting Octreotide (right)

Somatostatin Analogues are the ‘workhorse’ treatments for those living with NETs, particularly where syndromes are involved. Although it can sometimes seem like they are only associated with serotonin releasing tumours (i.e. what might be described as Carcinoid), these types of drugs can be used to help with other NET types including Pancreatic NETs, or pNETs for short. For example, the drugs can be used for treating insulinoma, gastrinoma, glucagonoma and VIPoma (all types of pNETs). They are most effective if the NETs express somatostatin receptors.

Somatostatin is actually a naturally occurring hormone produced by the hypothalamus and some other tissues such as the pancreas and the gastrointestinal tract. However, it can only handle the normal release of hormones.  When NET syndromes occur, the naturally occurring somatostatin is unable to cope. The word ‘analogue’ in the simplest of terms, means ‘manufactured’ and a somatostatin analogue is made to be able to cope with the excess secretion (in most cases).

Although there is hidden complexity, the concept of the drug is fairly simple.  It can inhibit insulin, glucagon, serotonin, VIP, it can slow down bowel motility and increase absorption of fluid from the gut. It also has an inhibitory effect on growth hormone release from the pituitary gland (thus why it’s also used to treat a condition called Acromegaly). You can see why it’s a good treatment for those with NET syndromes, i.e. who suffer from the excess secretions of hormones from their NETs.  Clearly there can be side effects as it also inhibits digestive enzymes which can contribute to, or exacerbate, gastro-intestinal malabsorption.

Please note somatostatin analogues are not chemo.  There are two major types in use:

  • Octreotide – or its brand name Sandostatin.  It is suffixed by LAR for the ‘long acting release’ version.
  • Lanreotide – brand name Somatuline (suffixed by ‘Depot’ in North America, ‘Autogel’ elsewhere)

A frequently asked question on forums is “what is the difference between Octreotide and Lanreotide?”

  • They are made by two different companies.  Novartis manufactures Octreotide and Ipsen manufactures Lanreotide.  Octreotide has been around for much longer.
  • The long-acting versions are made and absorbed very differently.  Octreotide has a complex polymer and must be injected in the muscle to absorb properly.  Lanreotide instead uses has a novel nanotube structure and is water based (click here to see a video of how this works). It is injected deep-subcutaneously and is therefore easier to absorb and is not greatly impacted if accidentally injected into muscle.
  • Their delivery systems are mainly via injections but are fundamentally different as you can see from the blog graphic which shows the differences between the long acting release versions.  Octreotide long acting requires a pre-mix, whilst Lanreotide comes pre-filled.
  • The long-acting versions are 60, 90 and 120 mg for Lanreotide and 10, 20 and 30 mg for Octreotide.
  • Octreotide also has a daily version which is administered subcutaneously.
  • Octreotide has something called a ‘rescue shot’ which is essentially a top up to tackle breakthrough symptoms.  It is a subcutaneous injection.
  • You can also ‘pump’ Octreotide using a switched on/off continuous infusion subcutaneously.
  • To the best of my knowledge, there is no daily injection, rescue shot or ‘pump’ for Lanreotide.
  • Whilst both have anti-tumour effects, there are slight differences in US FDA approval: Octreotide (Sandostatin) is approved for symptom control whereas Lanreotide (Somatuline) is approved for tumour control.

Here are some interesting videos showing and explaining their administration:

Administering a Somatuline Depot (Lanreotide) injection:

Administering a Sandostatin LAR (Octreotide) injection:

This link also provides guidance on the “new formulation” Octreotide.  Click here.

My own experience only includes daily injections of Octreotide (Sep-Nov 2010) and Lanreotide (Dec 2010 onwards).  I’ve also had continuous infusion of Octreotide in preparation for surgical or invasive procedures over the period 2010-2012 (i.e. crisis prevention).  You can read about my Lanreotide experience by clicking here.  If you are interested in what might be coming downstream, please see my blog entitled ‘Somatostatin Analogues and Delivery Systems in the Pipeline’.

Thanks for listening

Ronny

Hey Guys, I’m also active on Facebook which comprises the bulk of my award-winning community.  Like my page for even more news.

Disclaimer

My Diagnosis and Treatment History

Most Popular Posts


7 Comments

  1. Pam Mckinnis says:

    I just started taking Lanreotide and a few days later my stool started getting pale. Does anyone else have this as a side effect?

    Liked by 1 person

  2. Kris Lindberg says:

    Hi Ronny, can Lanreotide be used in conjunction with sub-q shots.

    Liked by 1 person

  3. cy says:

    Well done as usual Ronny. I have been on Sandostatin LAR for over 5 years. For a while 30mg monthly, then 40mg monthly, then 40mg every three weeks. Finally after liver surgery in 2013 back to 40mg monthly and in 2015 30mg monthly. This was all for syndrome control. I am still on it. Two months ago we found that 5 out of 6 tumors in my liver had shrunk to invisibility. I believe that the Sando plus the liver surgery which removed one very large tumor are the reason for this.

    Liked by 1 person

  4. Gaynor Miles says:

    Thanks again Ronny for your very informative blog

    Like

Thanks for the comment, make sure you have ticked the box to receive notifications of responses

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Blog Stats

  • 271,299 hits

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 8,693 other followers

Recent Posts

%d bloggers like this: